Skyland PIMS Democratizes Batch Data Management for AAV Gene Therapies and Accelerates CMO Collaboration
Leveraging multiple external partners, a leading clinical-stage biotechnology company manufactures AAV viral vectors as part of its proprietary gene delivery platform.